ARSArs Technica·1hHealth
score+0.85
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
Original
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
“Uses affirmative 'succeeded' and 'thwarted' to frame a major medical breakthrough, conveying high optimism.”